Syra Health Q4 2024 GAAP EPS $(0.05) Up From $(0.16) YoY
Syra Health 2024 Rev $8.0M >SYRA
Express News | Syra Health Corp - Expects Low Double-Digit Percentage Revenue Growth for FY2025
Express News | Syra Health Announces Full-Year Revenue of $8.0 Million, up 45% YoY
Press Release: Syra Health Announces Full-Year Revenue of $8.0 Million, Up 45% YoY
Earnings Scheduled For March 11, 2025
Syra Health (SYRA.US) will release its Earnings Reports before the market opens on March 11.
$Syra Health(SYRA.US)$ will release their Earnings Reports before the market opens on March 11, and investors should pay attention. How were the previous results? $Syra Health(SYRA.US)$ reported revenue of 2.2533 million USD and Net income of -0.4175 million USD with an EPS of -0.06 USD for Q3 2024. For Q4 2023, revenue was 1.7662 million USD, Net income was -0.9953 million USD, and EPS was -0.16 USD. The accounting standards used for the above data are US_GAAP. Futubull reminds: 1. The market is public in Hong Kong and the US.
Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results
Syra Health Secures Population Health Contract Extension in Shelby County, Tennessee
Express News | Syra Health Announces Preliminary Results From Syrenity Study Led By Indiana University
Express News | Syra Health Corp - Second Clinical Study to Test Statistical Significance Planned
Express News | Syra Health Corp - Preliminary Analysis Suggested Trends Toward Reduction in Depression Symptoms Among Syrenity Users
Syra Health Awarded Six-month, $135,000 Contract With Midwest-based University
Express News | Syra Health Corp. Awarded Six-Month $135,000 Healthcare Training Contract With A Midwest-Based University
Express News | Syra Health Corp Files for Mixed Shelf of up to $75 Mln - SEC Filing
Express News | Syra Health Says It Was Notified That Its Executive Chairman And President, Sandeep Allam, Had Passed Away
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Syra Health Awarded $1 Mln Contract For Healthcare Services In Washington D.C.
Why Is Syra Health Stock Surging Today?
Immuneering IMRX Phase 2a Data; Syra Health SYRA Workforce Contract